Dan Suesskind Purchases 60,000 Shares of Nano-X Imaging (NASDAQ:NNOX) Stock

Nano-X Imaging Ltd. (NASDAQ:NNOX) Director Dan Suesskind bought 60,000 shares of the business’s stock in a transaction on Monday, September 14th. The stock was purchased at an average price of $0.76 per share, with a total value of $45,600.00. Following the completion of the transaction, the director directly owned 110,000 shares of the company’s stock, valued at $83,600. This trade represents a 120.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

Nano-X Imaging Stock Performance

Shares of NNOX stock opened at $0.75 on Thursday. Nano-X Imaging Ltd. has a 1 year low of $0.67 and a 1 year high of $4.71. The business’s fifty day moving average is $0.93 and its 200-day moving average is $1.62. The stock has a market cap of $59.23 million, a PE ratio of -0.35 and a beta of 1.26.

Nano-X Imaging (NASDAQ:NNOX) last announced its quarterly earnings data on Wednesday, September 9th. The company reported ($0.79) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.63). The firm had revenue of $4.16 million during the quarter, compared to analyst estimates of $5.38 million. Nano-X Imaging had a negative net margin of 926.05% and a negative return on equity of 116.93%. Equities research analysts predict that Nano-X Imaging Ltd. will post -0.6 earnings per share for the current year.

Institutional Trading of Nano-X Imaging

Institutional investors and hedge funds have recently bought and sold shares of the stock. UBS Group AG boosted its holdings in shares of Nano-X Imaging by 40.8% in the fourth quarter. UBS Group AG now owns 1,530,104 shares of the company’s stock worth $4,284,000 after buying an additional 443,459 shares during the period. Bank of America Corp DE raised its holdings in shares of Nano-X Imaging by 711.1% during the first quarter. Bank of America Corp DE now owns 484,328 shares of the company’s stock valued at $1,099,000 after acquiring an additional 424,618 shares during the period. Griffin Asset Management Inc. lifted its position in shares of Nano-X Imaging by 47.4% in the 4th quarter. Griffin Asset Management Inc. now owns 170,309 shares of the company’s stock valued at $477,000 after acquiring an additional 54,790 shares in the last quarter. Royal Bank of Canada lifted its position in shares of Nano-X Imaging by 27.8% in the 1st quarter. Royal Bank of Canada now owns 194,166 shares of the company’s stock valued at $440,000 after acquiring an additional 42,273 shares in the last quarter. Finally, Sei Investments Co. acquired a new position in Nano-X Imaging in the 1st quarter worth approximately $98,000. Institutional investors and hedge funds own 21.49% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on NNOX. Weiss Ratings reissued a “sell (e+)” rating on shares of Nano-X Imaging in a research note on Wednesday, July 8th. Alliance Global Partners lowered shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $5.00 to $3.00 in a research report on Tuesday, July 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $5.00 price target on shares of Nano-X Imaging in a report on Monday, August 17th. Finally, Zacks Research upgraded Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Nano-X Imaging currently has a consensus rating of “Moderate Buy” and a consensus price target of $4.33.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. (NASDAQ:NNOX) is an Israeli medical technology company focused on expanding access to diagnostic imaging. The company develops digital X-ray systems and related software intended to provide affordable, digitally managed imaging services for hospitals, clinics, and other healthcare providers.

Its principal platform, Nanox.ARC, is a digital X-ray system designed around a proprietary cold-cathode X-ray source and a multi-source imaging architecture. The company also offers Nanox.CLOUD, a cloud-based platform intended to connect imaging devices with radiologists and healthcare networks, and Nanox.AI, software designed to assist with the detection and prioritization of findings in medical images.

Nano-X markets its technologies to customers and partners in multiple international markets, with regulatory clearances and commercial availability varying by product and jurisdiction.